Skip to main content
Powered by ShareScore

Find research datasets worth reusing

Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.

154

datasets available to search

ShareScore release 0.9.0

Reset

Dataset results

154 results for “systemic lupus erythematosus (SLE)”

Learn how ShareScore rates datasets ↗
ClinicalTrials.gov40/100

Dipyridamole Assessment for Flare Reduction in Systemic Lupus Erythematosus (SLE)

ClinicalTrials.gov study NCT01781611. IPD Sharing: YES. Countries: 1. Publications: 2.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov36/100

Efficacy and Safety of Belimumab in Black Race Patients With Systemic Lupus Erythematosus (SLE)

ClinicalTrials.gov study NCT01632241. IPD Sharing: YES. Countries: 6. Publications: 4.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov36/100

A Study to Evaluate the Efficacy and Safety of Belimumab Administered in Combination With Rituximab to Adult Subjects With Systemic Lupus Erythematosus (SLE) - BLISS-BELIEVE

ClinicalTrials.gov study NCT03312907. IPD Sharing: YES. Countries: 11. Publications: 5.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov36/100

Study of BOS161721 in Systemic Lupus Erythematosus (SLE) Patients on a Background of Limited Standard of Care

ClinicalTrials.gov study NCT03371251. IPD Sharing: Not stated. Countries: 12. Publications: 1.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov36/100

A Study to Evaluate the Effect of Belimumab on Vaccine Responses in Subjects With Systemic Lupus Erythematosus (SLE)

ClinicalTrials.gov study NCT01597492. IPD Sharing: YES. Countries: 1. Publications: 1.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov36/100

A Phase 2a of RSLV-132 in Subjects With Systemic Lupus Erythematosus (SLE)

ClinicalTrials.gov study NCT02660944. IPD Sharing: NO. Countries: 1. Publications: 1.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov36/100

Atacicept Phase 2/3 in Generalized Systemic Lupus Erythematosus (APRIL-SLE)

ClinicalTrials.gov study NCT00624338. IPD Sharing: Not stated. Countries: 29. Publications: 3.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov36/100

Biomarkers of Lupus Disease: Serial Biomarker Sampling in Patients With Active Systemic Lupus Erythematosus (SLE)

ClinicalTrials.gov study NCT00987831. IPD Sharing: Not stated. Countries: 1. Publications: 1.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov36/100

Acthar for the Treatment of Systemic Lupus Erythematosus (SLE) in Patients With a History of Persistently Active Disease

ClinicalTrials.gov study NCT01753401. IPD Sharing: NO. Countries: 1. Publications: 1.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov36/100

A Study of Baricitinib in Participants With Systemic Lupus Erythematosus (SLE-BRAVE II)

ClinicalTrials.gov study NCT03616964. IPD Sharing: YES. Countries: 15. Publications: 3.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov36/100

Mindfulness- Based Intervention for Systemic Lupus Erythematosus (SLE) Patients

ClinicalTrials.gov study NCT04305418. IPD Sharing: YES. Countries: 1. Publications: 14.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov36/100

Study of Epratuzumab Versus Placebo in Subjects With Moderate to Severe General Systemic Lupus Erythematosus (SLE)

ClinicalTrials.gov study NCT01261793. IPD Sharing: Not stated. Countries: 16. Publications: 2.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov36/100

Efficacy and Safety of AMG 570 in Subjects With Active Systemic Lupus Erythematosus (SLE)

ClinicalTrials.gov study NCT04058028. IPD Sharing: YES. Countries: 19. Publications: 2.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov36/100

A Study of Baricitinib (LY3009104) in Participants With Systemic Lupus Erythematosus (SLE)

ClinicalTrials.gov study NCT02708095. IPD Sharing: Not stated. Countries: 12. Publications: 4.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov36/100

A Study of Belimumab Administered Subcutaneously in Subjects With Systemic Lupus Erythematosus (SLE)

ClinicalTrials.gov study NCT01484496. IPD Sharing: YES. Countries: 31. Publications: 10.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov36/100

GSK1550188 A 52 Week Study of Belimumab Versus Placebo in the Treatment of Subjects With Systemic Lupus Erythematosus (SLE) Located in Northeast Asia

ClinicalTrials.gov study NCT01345253. IPD Sharing: Not stated. Countries: 3. Publications: 10.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov36/100

BEL114333, a Continuation Study of BEL113750 in Subjects With Systemic Lupus Erythematosus (SLE) in Northeast Asia, and in Japan Subjects Completing the Open-label Extension of HGS1006-C1115

ClinicalTrials.gov study NCT01597622. IPD Sharing: YES. Countries: 2. Publications: 1.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov36/100

A Study of Belimumab in Subjects With Systemic Lupus Erythematosus (SLE)

ClinicalTrials.gov study NCT00424476. IPD Sharing: YES. Countries: 13. Publications: 19.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov36/100

A DOSE-RANGING STUDY TO EVALUATE EFFICACY AND SAFETY OF PF-06700841 IN SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)

ClinicalTrials.gov study NCT03845517. IPD Sharing: YES. Countries: 26. Publications: 1.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov36/100

A Study to Investigate the Safety and Efficacy of Elsubrutinib and Upadacitinib Given Alone or in Combination in Participants With Moderately to Severely Active Systemic Lupus Erythematosus (SLE)

ClinicalTrials.gov study NCT03978520. IPD Sharing: YES. Countries: 21. Publications: 1.

controlledIPD-YESFeb 2026View details →

ScienceDex guides

Understand access before you commit

These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.

Compare curated datasets

Allen Brain Atlas

Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.

allen-brain-atlas
neuroscienceopenDocumentation, web resources, and API references are available online.
Last verified 2026-04-30Open record

Annotated Behaviour and Observability Dataset (ABODe)

ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.

abode-home-cage
behavioral-neuroscienceopenThe DataShare record exposes download links for annotations, documentation, license text, and the zipped per-snippet data directory.
Last verified 2026-04-30Open record

DANDI Archive for NWB datasets

DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.

dandi-nwb
electrophysiologyopenPublished Dandiset metadata and archive endpoints are available through the production DANDI API.
Last verified 2026-04-30Open record

International Brain Laboratory public data

The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.

ibl
behavioral-neuroscienceopenPublic sessions can be searched and loaded from the IBL public data server through ONE.
Last verified 2026-04-29Open record

OpenNeuro

OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.

openneuro
neuroscienceopenPublished datasets are available on demand over the internet.
Last verified 2026-04-29Open record